Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 739

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 739
---
       |     |        465.0 |
| Kymriah  |     | Follicular Lymphoma          |     | Novartis              |     |        475.0 |
| Lantidra |     | Type 1 Diabetes              |     | CellTrans             |     |        300.0 |
| Maci     |     | Knee/Joint defects           |     | Vericel               |     |         40.0 |
| Omisirge |     | Blood Cancers                |     | Gamida cells          |     |        338.0 |
| Provenge |     | Prostste cancer              |     | Dendreon              |     |         93.0 |
| Rethymic |     | Congenital Athymia           |     | Enzyvant Therapeutics |     |      2,700.0 |
| Tecartus |     | Acute Lymphoblastic Leukemia |     | Kite Pharma           |     |        373.0 |
| Yescarta |     | Large B-Cell Lymphoma        |     | Kite Pharma           |     |        373.0 |

____________ 4Gene and Cell Therapies: Navigating the Challenges Around Rising Costs in Medical Insurance ( https://www.guycarp.com/ )

| Moore Financial Consulting |

Annex E-18

Methodology Methodology for asset valuation A valuation of business, operations, assets or liabilities can be carried out according to one or more methodologies for valuation. For the most part, the general practice divides the valuation methodologies between the three following main approaches: •The Cost Approach/Net Asset Value (NAV). •The Comparative Method/Market Approach. •The Income/Earnings Approach Valuation methodology can make use of one or more of the approaches above. Choosing the appropriate valuation methodology varies from case to case. While each of the various approaches and methodologies has its own uniqueness and is suitable for other types of assets or evaluating various business situations. In addition, all the approaches require references to various parameters and different information available and therefore the choice of valuation methodology should be done carefully with attention to both the nature of the asset valued, the business environment in which it is located and the information available to the appraiser at the valuation. The Cost Approach/Net Asset Value (NAV) The cost approach estimates the economic value of the entity’s assets and liabilities based on their market value. To carry out the valuation